Evidence map›Paper›PMID 24038157›Full record

ArticleThe Prostate2013

Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence.

Scott R Bauer, Erin L Richman, Eduardo Sosa, Vivian Weinberg, Xiaoling Song, John S Witte, Peter R Carroll, June M Chan

Open access · greenAbstract read
In one paragraph

Article in The Prostate, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2016
    Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Extracellular superoxide dismutase and its role in cancer.Free radical biology & medicine · 2017
    Review
  15. Article
  16. Vitamins, metabolomics, and prostate cancer.World journal of urology · 2017
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Scott R BauerDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.
Erin L Richman
Eduardo Sosa
Vivian Weinberg
Xiaoling Song
John S Witte
Peter R Carroll
June M Chan
University of California, San Francisco · USFred Hutch Cancer Center · US

Funding

Training in Molecular& Genetic Epidemiology of CancerR25CA112355 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WITTE, JOHN S. · 2005 to 2018
$6.5M
Genetic Epidemiology of Prostate Cancer Risk and ProgressionR01CA088164 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VAN DEN EEDEN, STEPHEN K., WITTE, JOHN S. · 2000 to 2015
$6.1M
Prostate Microenvironmental & Prostate Cancer ProgressionR01CA106947 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHAN, JUNE ML · 2006 to 2009
$1.5M
NCI NIH HHS R01 CA088164NCI NIH HHS R01 CA106947NCI NIH HHS R25 CA112355
6 · The paper itself

Abstract

backgroundObservational studies suggest an inverse association between vitamin E and risk of prostate cancer, particularly aggressive tumors. However, three large randomized controlled trials have reported conflicting results. Thus, we examined circulating vitamin E and vitamin E-related genes in relation to risk of high-grade prostate cancer and prostate cancer recurrence among men initially diagnosed with clinically organ-confined disease.

methodsWe measured circulating α- and γ-tocopherol and genotyped 30 SNPs in SOD1, SOD2, SOD3, TTPA, and SEC14L2 among 573 men with organ-confined prostate cancer who underwent radical prostatectomy. We examined associations between circulating vitamin E, genotypes, and risk of high-grade prostate cancer (Gleason grade ≥ 8 or 7 with primary score ≥ 4; n = 117) using logistic regression, and risk of recurrence (56 events; 3.7 years median follow-up) using Cox proportional hazards regression.

resultsCirculating γ-tocopherol was associated with an increased risk of high-grade prostate cancer (Q4 v. Q1 odds ratio [OR] = 1.87; 95% confidence intervals [CI]: 0.97-3.58; P trend =0.02). The less common allele in SOD3 rs699473 was associated with an increased risk of high-grade disease (T > C: OR = 1.40, 95% CI: 1.04-1.89). Two independent SNPs in SOD1 were inversely associated with prostate cancer recurrence in additive models (rs17884057 hazard ratio [HR] = 0.49, 95%CI: 0.25-0.96; rs9967983 HR = 0.62, 95% CI: 0.40-0.95).

conclusionsAmong men with clinically organ-confined prostate cancer, genetic variation in SOD may be associated with risk of high-grade disease at diagnosis and disease recurrence. Circulating γ-tocopherol levels may also be associated with an increased risk of high-grade disease at diagnosis.

Indexed as

Agedalpha-TocopherolBiomarkers, TumorCarrier Proteinsgamma-TocopherolHumansLipoproteinsLogistic ModelsMaleMiddle AgedNeoplasm GradingNeoplasm Recurrence, LocalPolymorphism, Single NucleotideProportional Hazards ModelsProstatic NeoplasmsRetrospective Studiesalpha-Tocopherolalpha-tocopherol transfer proteinBiomarkers, TumorCarrier Proteinsgamma-TocopherolLipoproteinsSEC14L2 protein, humanSOD1 protein, humanSOD3 protein, humanSuperoxide DismutaseSuperoxide Dismutase-1Superoxide Dismutase 2Trans-ActivatorsVitamin Egenetic polymorphismsGleason gradeprostate cancerrecurrencevitamin E

Identifiers

PMID24038157
PMCPMC5501162
OpenAlexW2125697561

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.